Takeda Expands Patient Assistance in the U.S. During COVID-19 Crisis

Via Takeda

To our valued patients, customers and other stakeholders,

As the COVID-19 crisis continues to unfold, Takeda’s Patient Assistance Response team is working around the clock to help ensure that the people who need our medicines and treatments can continue to access them safely and without interruption.

Consistent with our commitment to prioritizing patients’ needs, Takeda has enhanced its existing patient assistance programs for U.S. patients who qualify and need extra help during this difficult time. Highlights include:

  • Implementing a new Job Loss Provision for Takeda’s Help at Hand program and Takeda’s Oncology Patient Support program to help eligible patients who have lost a job and are experiencing a financial hardship due to the COVID-19 pandemic. Click here for a listing of Takeda medicines available through the Takeda Help at Hand patient assistance and support program. Click here for Takeda’s Oncology Patient Support Program.
  • Enhancing free drug programs for eligible patients enrolled in Takeda’s OnePath, Entyvio Connect, Hematology Support Center, and Takeda’s Oncology Patient Support programs, who have experienced a loss or gap in insurance coverage due to COVID-19;
  • Extending the eligibility period for certain patients currently enrolled in Takeda’s patient assistance programs to help reduce the time patients spend on securing medication approvals so they can focus on their health and safety during the pandemic;
  • Implementing virtual training that pairs specially-trained nurses with patients to teach proper self- administration of certain Takeda medicines from the safety of patients’ own homes. For more information, see contact information for Takeda’s Patient Assistance Programs below. Takeda’s Patient Services Team is here to help you through this difficult time. For more information, as well as additional eligibility requirements, please refer to the following programs: For Takeda Help At Hand Patient Assistance Program (PAP), please call 1-800-830-9159, between 8:00am – 8:30pm ET, Monday through Friday For Entyvio Connect, please call 1-855-368-9846, between 8:00am –8:00pm ET, Monday through Friday For OnePath, please call 1-866-888-0660, between 8:30am – 8pm ET, Monday through Friday For Hematology Support Center, please call 1-888-229-8379, between 8:30am – 8pm ET, Monday through Friday For Takeda Oncology Patient Support, please call 1-844-817-6468, option 2, between 8:00am-8:00pm ET, Monday-Friday Sincerely, Daniel McNamara Dion Warren
    Head of U.S. Patient Services Head of U.S. Oncology Business Unit

MAA COVID-19 INFORMATION DISCLAIMER:

The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service.   The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.  

The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via this email or other communications.

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER